| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > Direct Mail Campaigns Versus Relationship Marketing |
|
Just Other Articles - Direct Mail Campaigns Versus Relationship Marketing
Direct mail campaigns are the first marketing strategy most new Network Consultants think of. Unfortuna According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product tely, direct mail campaigns are not always the most efficient or cost effective means of advertising; es ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ecially when you are first starting out. Direct Mail Campaign Comparison To launch a direct mail campa lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. gn you typically use postcards. Think about how many postcards you would have to mail out to get 100 pe here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ple’s attention for a few minutes. Now think about how easy it is to get 100 people’s ears for a few mi d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro nutes if you are on a panel for a Chamber of Commerce event and there are 100 people in the audience. D ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc rect mail campaigns pale in comparison. Suppose you run a direct mail campaign with a 1% response rate easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi which is very high unless you have an awesome bribe attached or an ace advertising copywriter). If you nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ail 10,000 postcards and you have to buy an expensive list of names it will cost you a minimum of $5000. and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ This $5000 investment in your direct mail campaign would get you 100 leads. Of those leads perhaps ano ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi her 1-2% will convert to clients. If you built a relationship with 1% of the people your direct mail ca ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a paign would have reached, your conversion rate would be much higher and you would not have had to part w dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod th $5000. With direct mail campaigns you are a stranger - you might be a stranger with a good sounding cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin deal but there is no trust. You are also an intrusion. With relationship marketing you achieve the oppo tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ite effects and as a result, much better outcomes. The Bottom Line on Direct Mail Campaigns Although d t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel rect mail campaigns are the things that new network consultants turn to for advertising they are not the ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust best choice. Direct mail campaigns are impersonal, expensive, and ineffective when compared to relation y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ship marketing. Spend your time building relationships rather than stamping postcards - the personal to . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ch is what will win you the business. Copyright MMI-MMVI, Computer Consulting 101. All Worldwide Rights elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip Reserved. {Attention Publishers: Live hyperlink in author resource box required for copyright compliance tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Executive Business Gifts As Sales Incentives Getting Past Major Learning Barriers Why You Should Never Hire Your Best Friend
|